Dr. Barton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2160 S 1st Ave
# Luh
Maywood, IL 60153Phone+1 708-216-3304Fax+1 708-216-1259
Education & Training
- University of ChicagoFellowship, Hematology and Medical Oncology, 1989 - 1994
- University of ChicagoResidency, Internal Medicine, 1986 - 1989
- Ohio State University College of MedicineClass of 1986
Certifications & Licensure
- IL State Medical License 1986 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Temsirolimus for Relapsed/Refractory Hodgkin's Lymphoma Start of enrollment: 2009 Jan 01
Publications & Presentations
PubMed
- 301 citationsAdenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in ...Mark W. Chang, Eliav Barr, Min Min Lu, Kevin P. Barton, Jeffrey M. Leiden
The Journal of Clinical Investigation. 1995-11-01 - 45 citationsPU.1 exhibits partial functional redundancy with Spi-B, but not with Ets-1 or Elf-1Lee Ann Garrett-Sinha, Richard Dahl, Sridhar Rao, Kevin P. Barton, M. Celeste Simon
Blood. 2001-05-01 - 132 citationsOverexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines.Christiane Houde, Yulin Li, Lynda Li Song, Kevin Barton, Qing Zhang
Blood. 2004-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: